Official press releases from pharmaceutical companies

New Study Shows 77.2% Improvement, 61% Eradication in Phage Therapy for 100 Cases

Jun 4, 2024, 05:39 PM

A new study published in Nature Microbiology reveals the outcomes of personalized bacteriophage therapy for 100 consecutive cases. Conducted by a Belgian consortium, the multicenter, multinational, retrospective observational study highlights a 77.2% clinical improvement rate and a 61% eradication rate in tough-to-treat salvage cases. The research, led by Paul Pirnay and his team, marks their 30th joint publication and underscores two decades of dedication to making phage therapy a viable treatment option. The study provides an objective measure of the success rate for phage therapy.